These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18381463)

  • 21. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.
    Kiemeney LA; van Houwelingen KP; Bogaerts M; Witjes JA; Swinkels DW; den Heijer M; Franke B; Schalken JA; Verhaegh GW
    Eur J Cancer; 2006 Dec; 42(18):3219-27. PubMed ID: 16934975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
    Brendle A; Lei H; Brandt A; Johansson R; Enquist K; Henriksson R; Hemminki K; Lenner P; Försti A
    Carcinogenesis; 2008 Jul; 29(7):1394-9. PubMed ID: 18550570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in the H19 gene and the risk of bladder cancer.
    Verhaegh GW; Verkleij L; Vermeulen SH; den Heijer M; Witjes JA; Kiemeney LA
    Eur Urol; 2008 Nov; 54(5):1118-26. PubMed ID: 18262338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
    Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
    Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan.
    Yen CY; Liu SY; Chen CH; Tseng HF; Chuang LY; Yang CH; Lin YC; Wen CH; Chiang WF; Ho CH; Chen HC; Wang ST; Lin CW; Chang HW
    J Oral Pathol Med; 2008 May; 37(5):271-7. PubMed ID: 18410587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
    Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
    Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
    Ohnami S; Sato Y; Yoshimura K; Ohnami S; Sakamoto H; Aoki K; Ueno H; Ikeda M; Morizane C; Shimada K; Sakamoto Y; Esaki M; Saito I; Hirose H; Saito D; Sugimura H; Kosuge T; Okusaka T; Yoshida T
    Gastroenterology; 2008 Aug; 135(2):477-88. PubMed ID: 18515090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTPRJ haplotypes and colorectal cancer risk.
    Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Oliveira E; Marrakchi R; Cherni L; Ben Othman F; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; Amorim A; Prata MJ; Benammar Elgaaied A
    Cancer Genet Cytogenet; 2009 Nov; 195(1):43-53. PubMed ID: 19837268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
    Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
    BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti- and proinflammatory cytokine gene polymorphism and genetic predisposition: association with smoking, tumor stage and grade, and bacillus Calmette-Guérin immunotherapy in bladder cancer.
    Ahirwar D; Kesarwani P; Manchanda PK; Mandhani A; Mittal RD
    Cancer Genet Cytogenet; 2008 Jul; 184(1):1-8. PubMed ID: 18558283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
    Gangwar R; Mandhani A; Mittal RD
    Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer.
    Cortessis VK; Siegmund K; Xue S; Ross RK; Yu MC
    Carcinogenesis; 2003 Oct; 24(10):1645-50. PubMed ID: 12896908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case-control study on JWA promoter -76G-->C polymorphism and the susceptibility of bladder cancer].
    Wu W; Li CP; Chen R; Cao XJ; Li AP; Wang Y; Yang KH; Qian LX; Liu QZ; Li ZL; Zhou JW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):648-52. PubMed ID: 16331563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.